PolarityTE

PolarityTE PEG

Delisted

The PEG Ratio (Price/Earnings-to-Growth) of PolarityTE (PTE) as of Nov 20, 2026 is -0.01.

PEG

-0.01

YoY

214.48%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of PolarityTE is 2022 -0.01 . PEG Ratio (Price/Earnings-to-Growth) of PolarityTE was 2021 -0.00 . It decreases by 214.48% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PolarityTE Stock analysis

What does PolarityTE do? PolarityTE Inc is an innovative biotechnology company specializing in tissue and organ regeneration. The company's developed technologies allow for the creation of functional human tissue from a patient's own stem cells. The history of PolarityTE Inc began in Utah, USA, in 2016 when the company was founded by Dr. Denver Lough, a plastic surgeon. Dr. Lough and his team had a vision to build a new type of medical company that not only addresses the symptoms of diseases but also their root causes. PolarityTE Inc operates on a unique business model based on holistic and personalized medicine. The company utilizes state-of-the-art technologies to offer personalized therapies for patients suffering from a variety of conditions, including burns, wounds, scleroderma, and other tissue-damaging diseases. The different divisions of PolarityTE Inc include research and development of innovative drugs and technologies, clinical trials, product launches, and collaboration with experts from various fields to continuously improve the offering of products and services. The company offers a range of products made from regenerative tissue. The portfolio of PolarityTE Inc includes SkinTE, OsteoTE, and CartTe, each tailored to the specific needs of patients. SkinTE is a groundbreaking therapy for regenerating skin tissue, designed to accelerate the repair of damaged skin. The treatment aims to reduce the need for skin grafts and expedite the healing process of wounds and burns. OsteoTE is an innovative method for regenerating bone tissue, with the potential to revolutionize the treatment of bone fractures. The treatment utilizes the regenerative abilities of cells to promote the growth of healthy bone and expedite the healing of fractures. CartTe is a therapy for regenerating cartilage tissue, aiming to help people with joint pain and discomfort. The treatment harnesses the body's ability to repair damaged tissue, stimulating the growth of novel cartilage cells and improving joint function. Overall, PolarityTE Inc has the potential to revolutionize the treatment of wounds and diseases. The company focuses on personalized medicine based on individual patient needs and promotes the development of therapies targeting the root causes of diseases. PolarityTE is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PolarityTE stock

PEG Ratio (Price/Earnings-to-Growth) of PolarityTE is -0.01 in 2022.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) PolarityTE since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s PolarityTE with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — PolarityTE

All Key Metrics — PolarityTE